Clinical trial · Interventional
Development of an Educational Patient Decision Aid (Treatments in Advanced Cancer - Decision Aid, TA-DA) to Promote Shared Decision Making for Third-line or Beyond Palliative Systemic Therapy
NCT07009886CI-TRIAL-00121760recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To develop an educational patient decision aid for advanced cancer patients to prepare them to have conversations with their clinicians about treatment options (Treatments in Advanced cancer - Decision Aid, TA-DA).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Advanced Cancer | Malignant Neoplasm | CURATED_BROADER | 0.78 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Communication | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- TA-DA
- description
- Patient and caregiver participants are presented with a prototype version of TA-DA and participate in interviews over 90 minutes to further refine the tool.
- interventionNames
- Other: Communication
- type
- EXPERIMENTAL
- label
- EUC
- description
- Patient and caregiver participants are presented with a prototype version of TA-DA and participate in interviews over 90 minutes to further refine the tool.
- interventionNames
- Other: Communication
Primary outcomes (1)
- measure
- Safety and Adverse Events (AEs)
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria:
1. Clinicians (Part I/II/III):
MD Anderson medical oncologists and APPs who provide care to patients with advanced cancer
2. Patients (Part I/II/III):
Age 18 or over
* Diagnosis of advanced cancer (i.e., metastatic, relapsed, and/or incurable disease as defined by the treating oncologist) who has received at least 2 lines of palliative systemic therapy\*
* Patient-rated ECOG performance status of 1-3 for Part I/II and 2-3 for Part III
* Able to make treatment decisions based on the clinical judgement of the oncology team
* English speaking
* patient has started, is receiving, and/or has completed second-line palliative systemic therapy or beyond
3. Caregivers (Part I/II/III):
* Age 18 or older
* Currently a primary caregiver to a patient who satisfies the patient eligibility criteria listed above
* For the study purposes, a primary caregiver is defined as:
* someone who provides physical, emotional, decisional and/or logistical assistance to the patient regularly (e.g. daily, weekly);
* can be a family member, friend, or other individual in a close relationship with the patient;
* must be identified by the patient and self-identify as the primary person providing caregiving support to the patient
* Able to provide informed consent and participate in the study
* English speaking
Exclusion Criteria:
Any patient who meets any of the following criteria will be excluded from participation in this study:
* (Part I/II/III): Diagnosis of cognitive impairment or dementia requiring a surrogate decision maker as determined by the clinical team
* (Part III only): Participants in Part I and IIReferences
Publications (0)
Data not yet available
No reference posted for this study.